Hypothesis-Driven Experimental Design & Troubleshooting
Design rigorous experiments with anticipated failure modes and structured troubleshooting logic
What You Can Do
You can systematically design experiments from hypothesis to protocol, anticipate technical and biological failure modes before lab work begins, and troubleshoot failed assays with structured diagnostic logic. This skill helps you validate experimental logic, specify comprehensive controls (positive, negative, vehicle), define acceptance criteria and detection limits, and document decision points—ensuring your team invests reagents and time only on scientifically sound approaches.
Features
Structure your research question, predicted outcome, and testable null hypothesis before protocol design
Specify positive controls, negative controls, vehicle controls, and internal standards tailored to your assay type
Identify anticipated technical failures (instrumentation, reagent degradation, sample handling) and biological confounders before experiments start
Generate SOPs with explicit acceptance criteria, troubleshooting checkpoints, and go/no-go decision points
Systematically rule out instrumental, reagent, or technical causes versus true biological signal when experiments fail
Design factorial or sequential experiments for compound/candidate screening with interpretation logic
Structure one-factor-at-a-time (OFAT) or factorial designs for parameter optimization (pH, temperature, incubation time, dose ranges)
Map raw results to biological conclusions with explicit reasoning for what results support or refute your hypothesis
Example Output
Example 1: Receptor Binding Assay Protocol
Input: "Design a cell-based assay to measure compound potency against the X7 receptor using fluorescence readout."
Output:
- Hypothesis: Compounds with >50% receptor occupancy at nanomolar concentrations will show ≥2-fold fluorescence increase
- Positive control: Known agonist (EC50 = 5 nM); negative control: known antagonist; vehicle control: DMSO only
- Failure modes: (1) Fluorescent signal too low—troubleshoot: increase cell density, extend incubation time, validate antibody lot; (2) High vehicle background—troubleshoot: optimize cell wash steps, reduce DMSO %, validate reagent freshness
- Acceptance criteria: Positive control EC50 = 3–7 nM, Z-factor ≥0.5, CV <15% within plate
Example 2: Failed In Vivo Study Troubleshooting
Input: "Our compound X showed 80% in vitro activity but zero efficacy in the mouse model. Help me rule out causes systematically."
Output:
- Technical diagnostics: Was dosing correct? Confirm PK sampling shows compound reaches target tissue. Was the route (oral vs. IV) appropriate for bioavailability?
- Assay validation: Confirm positive control compound works in same model. Is the efficacy readout (imaging, biomarker, behavior) sensitive enough?
- Biological factors: Does compound have off-target toxicity? Did animal cohort have sufficient disease phenotype? Is the target engaged at intended dose?
- Next step decision tree: If PK is low → reformulation; if target engaged but no efficacy → mechanism of action issue; if positive control also fails → model validity issue
What's Included
- SKILL.md instruction file: Core framework for hypothesis validation, control design, and failure mode analysis
- Experimental Design Template: Structured worksheet for hypothesis, predicted outcomes, control specifications, and acceptance criteria
- Failure Mode & Effects Analysis (FMEA) Checklist: Systematic list of technical, reagent, and biological failure modes by assay type (cell-based, biochemical, in vivo)
- Troubleshooting Decision Tree: Flowchart for ruling out instrumental vs. reagent vs. biological causes when experiments fail
- Protocol Documentation Framework: SOP template with decision points, go/no-go criteria, and interpretation logic built in
Who It's For
- Research Scientists in pharma/biotech designing and validating new assays, screens, or in vivo studies
- Assay Development Scientists optimizing biochemical, cell-based, or phenotypic readouts for compound/candidate evaluation
- Preclinical Project Leads troubleshooting failed experiments and documenting protocols for team handoff
- Process Development Scientists designing factorial experiments for manufacturing scale-up and optimization
- Biomarker Development Teams validating new diagnostic or predictive assays with rigorous controls and failure mode planning
Best For
- New assay design and validation — Define controls, detection limits, and acceptance criteria before lab setup
- Experimental troubleshooting — Systematically rule out technical causes from true biological signal in failed experiments
- Protocol documentation — Write SOPs with explicit decision points, acceptance criteria, and interpretation logic
- Compound or candidate screening — Design multi-endpoint evaluation frameworks with go/no-go criteria
- Assay optimization — Structure factorial or sequential designs for parameter optimization (dose ranges, incubation times, reagent concentrations)
You might also like
You can design experiments with appropriate controls, replicate structures, and sample sizes before conducting any bench work. This skill helps you establish clear endpoints, identify confounding variables, select the right statistical tests, and create reproducible data collection protocols—preventing costly failed experiments and increasing publishability.
by kody-w
You can design and execute bioanalytical method validations aligned with FDA Guidance for Industry and ICH guidelines, interpret complex validation data against regulatory acceptance criteria, and systematically troubleshoot analytical failures to identify root causes and corrective actions. This skill accelerates validation timelines by 20–30%, minimizes regulatory rework, and provides structured decision trees for problems that typically require expert consultation.
by kody-wClaude reviews your injection mold, stamping die, or precision tool designs for manufacturability, cost reduction opportunities, and tolerance optimization. You provide CAD specifications, material details, and production volume—Claude identifies specific design modifications, material alternatives, and tolerance adjustments that reduce tooling complexity and unit costs without compromising performance.
by kody-w
Conduct comprehensive job risk assessments in minutes, generate detailed task analysis reports with biomechanical findings, and develop prioritized ergonomic interventions backed by OSHA and NIOSH guidelines. You'll identify risk factors, quantify hazard severity, and produce actionable recommendations that reduce worker injury rates and improve compliance documentation.
by kody-w
You can automate the validation of clinical trial data against protocol specifications, identify discrepancies including missing values, out-of-range results, protocol violations, and CRF inconsistencies. The skill generates audit-ready query documentation, categorizes anomalies by severity and type, resolves root causes systematically, and produces FDA inspection-ready reports that trace every data decision and corrective action for CDISC and regulatory submission.
by kody-w
Analyze your power system topology, coordinate protective devices for optimal selectivity and speed, and generate comprehensive arc flash hazard analyses compliant with IEEE 1584. You get fault current calculations, device coordination plots, and hazard risk assessments that guide equipment upgrades and safety training.
by kody-w
You can rapidly diagnose why your solid dose formulations are failing—whether due to poor flowability, insufficient hardness, moisture sensitivity, dissolution issues, or API degradation. The skill walks you through structured root-cause analysis, maps chemical interactions between your drug substance and excipients across pH, temperature, and moisture conditions, then prioritizes excipient replacements based on regulatory precedent and manufacturing feasibility. You'll document all decisions with clear rationale ready for CMC submissions.
by kody-w
You consolidate parallel data streams from preclinical toxicology studies (clinical pathology, histopathology, body weight changes, organ weights, clinical observations, mortality) into coherent regulatory-compliant narratives. This skill synthesizes findings across 6–12 endpoints simultaneously, identifies NOAEL/LOAEL with biological justification, determines safety margins, interprets species-specific or sex-specific signals, and produces Results & Discussion sections that satisfy FDA/EMA reviewers while supporting appropriate dosing decisions for IND-enabling studies.
by kody-w